What target pralidoxime concentration?
Dawson
A
A
Buckley
N
N
Whyte
I
I
D000931:Antidotes / Q000493:pharmacokinetics*; D002801:Cholinesterase Reactivators / Q000493:pharmacokinetics*; D006801:Humans; D007262:Infusions, Intravenous; D011220:Pralidoxime Compounds / Q000493:pharmacokinetics*
D000931:Antidotes; D002801:Cholinesterase Reactivators; D011220:Pralidoxime Compounds; C028797:pralidoxime